
Thermo Fisher Scientific Inc.
TMO 515.98 (-0.13%) 0.68
Health Care
Life Sciences Tools and Services
Quality Checklist 6/8
5Y Shares Out Change < 0%
Debt/Equity < 1
Current Ratio > 1
Quick Ratio > 1
Net Margin > 10%
Est. EPS Growth > 5%
ROIC > 10%
Past Net Income CAGR > 0%
0.0%of Portfolio
My holdings
Day change:
Total change:
Shares:Cost basis:
Market cap: $193.86(B)
EV: $226.77(B)
Total Equity: $53.54(B)
Earnings date: Apr-22-2026
P/E: 29.02
Forward P/E: 21.03
P/FCF: 30.82
P/S: 4.37
P/B: 3.63
EPS: $17.8
EPS (fwd): $24.5
FCF/share: $16.7
Revenue/share: $118.2
Book value/share: $142.1
ROIC: 7.7%
ROA: 6.5%
ROE: 13.1%
Debt/Equity: 0.74
Current Ratio: 1.90
Gross margin: 41.7%
Operating margin: 18.4%
Net margin: 15.0%
Dividend/share: $1.7
Div. yield: 0.33%
TMO Valuation & Price Targets
Current Price
$516
Favorite Valuation Methods
More Valuation Methods
DCF (simple)
N/A
N/A
DCF (exit mult.)
N/A
N/A
DDM
N/A
N/A
EPS growth
N/A
N/A
Revenue growth
N/A
N/A
Peter Lynch FV
N/A
N/A
Graham No.
N/A
N/A
PEvaluation
19% overvalued
Low
$313
Mid
$417
High
$522
Current price
$516
Fair P/E
Margin of safety
EPS
Market Model
Economic moat: Medium
EPS Estimates
| Low | Avg | High | # | |
| FY+1 | 21.8 | 24.5 | 25.9 | 28 |
| FY+2 | 26.4 | 26.9 | 28.4 | 25 |
| FY+3 | 28.9 | 29.7 | 30.5 | 13 |
| FY+4 | 32.4 | 33.1 | 34.7 | 4 |
| FY+5 | 36.2 | 37.8 | 39.4 | 2 |
Analyst Price Targets
30% undervalued
Low
$595
Mid
$670
High
$750
Current price
$516
Analyst Recommendations
2-stage DCF
First Stage Duration: 5 Years | |
| Starting Free Cash Flow | |
First Stage Growth Rate | |
LowMidHigh | |
Terminal Growth Rate | |
LowMidHigh | |
| Discount Rate | |
Discounted Cash Flow
Forecast years: 5 Years | |
Terminal Growth Rate | |
LowMidHigh | |
| Discount Rate | |
Free cash flow estimates:
Discounted Cash Flow (exit mult.)
Forecast years: 5 Years | |
Exit FCF Multiple | |
LowMidHigh | |
| Discount Rate | |
Free cash flow estimates:
Dividend Discount Model
| Annual Dividend | |
First Stage Length (Years): 0 Years | |
| First Stage Growth Rate | |
| Final Growth Rate | |
| Discount Rate | |
EPS Growth
Forecast years: 5 Years | |
| Starting EPS | |
EPS Growth Rate | |
LowMidHigh | |
Final P/E | |
LowMidHigh | |
| Discount Rate | |
Revenue Growth Valuation
Forecast Years: 10 Years | |
| Base Revenue | |
Revenue Growth Rate | |
LowMidHigh | |
Final Net Margin | |
LowMidHigh | |
Final P/E Ratio | |
LowMidHigh | |
| Discount Rate | |
Peter Lynch Fair Value
| Earnings Per Share | |
| Growth Rate |
Graham Formula
| Earnings Per Share | |
| EPS Growth (7-10 years) | |
| Government Bond Rate |
